Arovella Therapeutics Ltd (FRA:E4NA)
€ 0.106 0.001 (0.95%) Market Cap: 124.02 Mil Enterprise Value: 121.87 Mil PE Ratio: 0 PB Ratio: 17.27 GF Score: 28/100

Arovella Therapeutics Ltd Webinar Presentation Transcript

Apr 04, 2023 / 01:00AM GMT
Release Date Price: €0.0245 (+4.26%)
Operator

Presentation
Apr 04, 2023 / 01:00AM GMT

=====================
Corporate Participants
=====================
* Michael Baker
Arovella Therapeutics - CEO and Managing Director

=====================

Michael Baker
Arovella Therapeutics - CEO and Managing Director

Thank you for standing by, and welcome to the Arovella Therapeutics, iNKT cell platform, explanatory webinar and Q&A today. All participants are in a listen-only mode. There will be an initial presentation lasting for approximately 30 to 35 minutes, followed by Q&A based on questions received via e-mail and those that come through live.

If you do have a question, you'd like to submit live, please feel free to do it using the Q&A function on the Zoom app, and we will get to those at the end. Appearing on behalf of our goals, today we have the CEO and Managing Director, Dr. Michael Baker, Senior VP of Development and Translational Medicine, Dr. Mini Bharathan and COO Nicole Van Der. To begin, I'll hand it over to Michael. Please go ahead.

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot